The FIB-4 index, a noninvasive test composed of AST, ALT, platelets and age, can be used to predict the stage of liver fibrosis and has been shown to be a predictive marker of HCC occurrence in patients with a variety of liver diseases [16,17,18,19]. This evidence concerns the gene GPT and liver disorder.